Maureen Murphy
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 3
- HER2/EGFR in Cancer Research 3
- Peptidase Inhibition and Analysis 1
- Cancer Treatment and Pharmacology 1
-
- Lymphoma Diagnosis and Treatment 1
- Co-authors
- Stanford J. Stewart (4 shared papers)Steven Shak (3 shared papers)Dennis J. Slamon (4 shared papers)Michael Burchmore (3 shared papers)Melody Cobleigh (3 shared papers)Debu Tripathy (3 shared papers)Mark Ashby (1 shared paper)Clifford A. Hudis (1 shared paper)
- Partner nations
- United States
In The Last Decade
Maureen Murphy
6 papers receiving 2.9k citations
Maureen Murphy's Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 1.9k
- Radiology, Nuclear Medicine and Imaging 869
- Cardiology and Cardiovascular Medicine 717
- Cancer Research 306
- Pulmonary and Respiratory Medicine 371
Countries citing papers authored by Maureen Murphy
This map shows the geographic impact of Maureen Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Murphy more than expected).
Fields of papers citing papers by Maureen Murphy
This network shows the impact of papers produced by Maureen Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Murphy. The network helps show where Maureen Murphy may publish in the future.
Co-authors
The 25 scholars most cited alongside Maureen Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer Hit paper breakdown → | 2002 | 1509 |
| 2 | Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience Hit paper breakdown → | 2002 | 1143 |
| 3 | 2004 | 221 | |
| 4 | 2002 | 112 | |
| 5 | 2023 | 19 | |
| 6 | 2016 | 1 |
About Maureen Murphy
Maureen Murphy is a scholar working on Oncology, Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine, Infectious Diseases and Organic Chemistry, having authored 6 papers that have together received 3.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Lymphoma Diagnosis and Treatment (1 paper), Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Peptidase Inhibition and Analysis (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Oncology (1.9k citations), Radiology, Nuclear Medicine and Imaging (869 citations), Cardiology and Cardiovascular Medicine (717 citations), Cancer Research (306 citations) and Pulmonary and Respiratory Medicine (371 citations). Maureen Murphy has collaborated with scholars based in United States. Frequent co-authors include Stanford J. Stewart, Steven Shak, Dennis J. Slamon, Michael Burchmore, Melody Cobleigh, Debu Tripathy, Mark Ashby, Clifford A. Hudis, Andrew D. Seidman and Virginia Paton. Their work appears in journals such as Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.